Pediatrix Medical Group Inc [MD] stock prices are down -0.08% to $12.29 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MD shares have gain 3.89% over the last week, with a monthly amount glided 14.33%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Pediatrix Medical Group Inc [NYSE: MD] stock has seen the most recent analyst activity on September 26, 2024, when Jefferies upgraded its rating to a Buy and also boosted its price target to $14 from $8. Previously, Deutsche Bank upgraded its rating to Hold on June 07, 2024, and kept the price target unchanged to $8. On September 27, 2021, SVB Leerink initiated with a Mkt Perform rating and assigned a price target of $29 on the stock. Deutsche Bank downgraded its rating to a Sell and reduced its price target to $12 on October 19, 2020. Citigroup downgraded its rating to Neutral for this stock on January 03, 2020, but kept the price target unchanged to $29. In a note dated December 12, 2019, Stifel upgraded an Buy rating on this stock and boosted its target price from $25 to $33.
The stock price of Pediatrix Medical Group Inc [MD] has been fluctuating between $6.62 and $13.01 over the past year. Currently, Wall Street analysts expect the stock to reach $18.17 within the next 12 months. Pediatrix Medical Group Inc [NYSE: MD] shares were valued at $12.29 at the most recent close of the market. An investor can expect a potential return of 47.84% based on the average MD price forecast.
Analyzing the MD fundamentals
The Pediatrix Medical Group Inc [NYSE:MD] reported sales of 2.00B for trailing twelve months, representing a surge of 0.74%. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at -0.13%, and Net Profit Margin reading is -0.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.28 and Total Capital is 0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.16 points at the first support level, and at 12.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.48, and for the 2nd resistance point, it is at 12.66.
Ratios To Look Out For
It’s worth pointing out that Pediatrix Medical Group Inc [NYSE:MD]’s Current Ratio is 1.38. As well, the Quick Ratio is 1.38, while the Cash Ratio is 0.06. Considering the valuation of this stock, the price to sales ratio is 0.53, the price to book ratio is 1.49.
Transactions by insiders
Recent insider trading involved Swift James D, Chief Executive Officer, that happened on Aug 30 ’24 when 11100.0 shares were sold. Officer, Swift James D completed a deal on Aug 30 ’24 to buy 11100.0 shares. Meanwhile, Director Linynsky Laura A sold 7000.0 shares on Aug 27 ’24.
